First trimester biomarkers in the prediction of later pregnancy complications

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kane, Stefan C ^a   Da Silva Costa, Fabricio ^a,b,c   Brennecke, Shaun ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Monash Ultrasound for Women   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOGLIN; INHIBIN A; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN TYROSINE KINASE; SEX HORMONE BINDING GLOBULIN; VASCULOTROPIN;

CLINICAL PRACTICE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; NULLIPARA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; REVIEW; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY; EARLY DIAGNOSIS; FEMALE; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS;

BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST;

EID: 84899529514     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/807196     Document Type: Review

References (64)

1. NHS National Institute for Health and Clinical Excellence, Antenatal care. NICE Clinical Guideline 62, London, UK, 2010
2. Cuckle H. S.; Screening for pre-eclampsia-lessons from aneuploidy screening. Placenta 2011 32 S42 S48 2-s2.0-79251498615 10.1016/j.placenta.2010. 07.015
3. Atkinson A.J. J.; Colburn W. A.; DeGruttola V. G.; DeMets D. L.; Downing G. J.; Hoth D. F.; Oates J. A.; Peck C. C.; Schooley R. T.; Spilker B. A.; Woodcock J.; Zeger S. L.; Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 2001 69 3 89 95 2-s2.0-0035100888 10.1067/mcp.2001.113989 (Pubitemid 32225406)
4. Duckitt K.; Harrington D.; Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal 2005 330 7491 565 567 2-s2.0-15044344544 10.1136/bmj.38380.674340.E0 (Pubitemid 40380349)
5. Esplin M. S.; O'Brien E.; Fraser A.; Kerber R. A.; Clark E.; Simonsen S. E.; Holmgren C.; Mineau G. P.; Varner M. W.; Estimating recurrence of spontaneous preterm delivery. Obstetrics and Gynecology 2008 112 3 516 523 2-s2.0-55949116168 10.1097/AOG.0b013e318184181a
6. Khambalia A. Z.; Ford J. B.; Nassar N.; Occurrence and recurrence of diabetes in pregnancy. Diabetic Medicine 2013 30 4 452 456
7. Voskamp B. J.; Kazemier B. M.; Ravelli A. C.; Recurrence of small-for-gestational-age pregnancy: analysis of first and subsequent singleton pregnancies in The Netherlands. American Journal of Obstetrics & Gynecology 2013 208 5 374.e1
8. Poon L. C. Y.; Kametas N. A.; Maiz N.; Akolekar R.; Nicolaides K. H.; First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009 53 5 812 818 2-s2.0-70349338116 10.1161/HYPERTENSIONAHA.108.127977
9. Park F. J.; Leung C. H.; Poon L. C.; Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2013 53 6 532 539
10. Scazzocchio E.; Figueras F.; Crispi F.; Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. American Journal of Obstetrics & Gynecology 2013 208 203.e1 203.e10
11. Greco E.; Gupta R.; Syngelaki A.; Poon L. C. Y.; Nicolaides K. H.; First-trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Fetal Diagnosis and Therapy 2012 31 3 154 161 2-s2.0-84860337957 10.1159/000335686
12. Maged A. M.; Moety G. A.; Mostafa W. A.; Hamed D. A.; Comparative study between different biomarkers for early prediction of gestational diabetes mellitus. Journal of Maternal-Fetal and Neonatal Medicine 2013 10.3109/14767058.2013.850489
13. Nanda S.; Savvidou M.; Syngelaki A.; Akolekar R.; Nicolaides K. H.; Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenatal Diagnosis 2011 31 2 135 141 2-s2.0-78650830097 10.1002/pd.2636
14. Karagiannis G.; Akolekar R.; Sarquis R.; Wright D.; Nicolaides K. H.; Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagnosis and Therapy 2011 29 2 148 154 2-s2.0-79952985204 10.1159/000321694
15. Poon L. C.; Syngelaki A.; Akolekar R.; Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagnosis and Therapy 2013 33 1 16 27
16. North R. A.; McCowan L. M. E.; Dekker G. A.; Poston L.; Chan E. H. Y.; Stewart A. W.; Black M. A.; Taylor R. S.; Walker J. J.; Baker P. N.; Kenny L. C.; Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. British Medical Journal 2011 342 7803 2-s2.0-79955409868 10.1136/bmj.d1875 d1875
17. Dugoff L.; Hobbins J. C.; Malone F. D.; Porter T. F.; Luthy D.; Comstock C. H.; Hankins G.; Berkowitz R. L.; Merkatz I.; Craigo S. D.; Timor-Tritsch I. E.; Carr S. R.; Wolfe H. M.; Vidaver J.; D'Alton M. E.; First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). American Journal of Obstetrics and Gynecology 2004 191 4 1446 1451 2-s2.0-7044251939 10.1016/j.ajog.2004.06.052 (Pubitemid 39421612)
18. Nicolaides K. H.; Turning the pyramid of prenatal care. Fetal Diagnosis and Therapy 2011 29 3 183 196 2-s2.0-79954998794 10.1159/000324320
19. Duley L.; The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology 2009 33 3 130 137 2-s2.0-65649125690 10.1053/j.semperi.2009.02.010
20. Cnossen J. S.; Vollebregt K. C.; De Vrieze N.; Ter Riet G.; Mol B. W. J.; Franx A.; Khan K. S.; Van Der Post J. A. M.; Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis. BMJ 2008 336 7653 1117 1120 2-s2.0-44349136394 10.1136/bmj.39540.522049.BE (Pubitemid 351731742)
21. Poon L. C. Y.; Kametas N. A.; Pandeva I.; Valencia C.; Nicolaides K. H.; Mean arterial pressure at 11 + 0 to 13 + 6 weeks in the prediction of preeclampsia. Hypertension 2008 51 4 1027 1033 2-s2.0-40849085498 10.1161/HYPERTENSIONAHA.107.104646 (Pubitemid 351398960)
22. Cnossen J. S.; Morris R. K.; Ter Riet G.; Mol B. W. J.; Van Der Post J. A. M.; Coomarasamy A.; Zwinderman A. H.; Robson S. C.; Bindels P. J. E.; Kleijnen J.; Khan K. S.; Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Canadian Medical Association Journal 2008 178 6 701 711 2-s2.0-41149176488 10.1503/cmaj.070430 (Pubitemid 351441471)
23. Velauthar L.; Zamora J.; Aquilina J.; Prediction of pre-eclampsia using first trimester uterine artery Doppler: a meta-analysis of 43 122 pregnancies. Ultrasound in Obstetrics & Gynecology 2012 40 supplement 1 49
24. Spencer K.; Cowans N. J.; Chefetz I.; Tal J.; Meiri H.; First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound in Obstetrics and Gynecology 2007 29 2 128 134 2-s2.0-33847277304 10.1002/uog.3876 (Pubitemid 46326583)
25. Salomon L. J.; Benattar C.; Audibert F.; Fernandez H.; Duyme M.; Taieb J.; Frydman R.; Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. American Journal of Obstetrics and Gynecology 2003 189 6 1517 1522 2-s2.0-0347987986 10.1016/S0002-9378(03)00902-5 (Pubitemid 38056417)
26. Ong C. Y. T.; Liao A. W.; Munim S.; Spencer K.; Nicolaides K. H.; First-trimester maternal serum activin a in pre-eclampsia and fetal growth restriction. Journal of Maternal-Fetal and Neonatal Medicine 2004 15 3 176 180 2-s2.0-2542466920 10.1080/14767050410001668275 (Pubitemid 38686024)
27. Wikström A.-K.; Larsson A.; Eriksson U. J.; Nash P.; Nordén-Lindeberg S.; Olovsson M.; Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstetrics and Gynecology 2007 109 6 1368 1374 2-s2.0-34249908643 10.1097/01.AOG.0000264552.85436.a1 (Pubitemid 46869876)
28. Akolekar R.; De Cruz J.; Foidart J.-M.; Munaut C.; Nicolaides K. H.; Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia. Prenatal Diagnosis 2010 30 3 191 197 2-s2.0-77349114204 10.1002/pd.2433
29. Foidart J.-M.; Munaut C.; Chantraine F.; Akolekar R.; Nicolaides K. H.; Maternal plasma soluble endoglin at 11-13 weeks' gestation in preeclampsia. Ultrasound in Obstetrics and Gynecology 2010 35 6 680 687 2-s2.0-77953583986 10.1002/uog.7621
30. Papantoniou N.; Bagiokos V.; Agiannitopoulos K.; RASSF1A in maternal plasma as a molecular marker of preeclampsia. Prenatal Diagnosis 2013 33 682 687
31. Roberge S.; Nicolaides K. H.; Demers S.; Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound in Obstetrics & Gynecology 2013 41 5 491 499
32. The ASPRE trial: combined multi-marker screening and randomised patient treatment with Aspirin for evidence-based PRE-eclampsia prevention. International Standard Randomised Controlled Trials Number 10.1186/ ISRCTN13633058
33. Hofmeyr G. J.; Lawrie T. A.; Atallah A. N.; Duley L.; Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews 2010 8 CD001059 2-s2.0-77955954066
34. The EPPI Trial-Enoxaparin for the Prevention of Preeclampsia and Intrauterine growth restriction-a pilot randomised open-label trial. ACTRN12609000699268
35. Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia-Folic Acid Clinical Trial (FACT). NCT01355159
36. Prevention of Adverse Pregnancy Outcome with Vitamin D Supplementation During Pregnancy. NCT01418664
37. Pravastatin for the Prevention of Preeclampsia in High-Risk Women: A Phase I Pilot Study. NCT01717586
38. Rattihalli R.; Smith L.; Field D.; Prevention of preterm births: are we looking in the wrong place? The case for primary prevention. Archives of Disease in Childhood: Fetal and Neonatal Edition 2012 97 F160 F161
39. Voltolini C.; Torricelli M.; Conti N.; Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Reproductive Sciences 2013 20 11 1274 1292
40. Menon R.; Torloni M. R.; Voltolini C.; Torricelli M.; Merialdi M.; Betrán A. P.; Widmer M.; Allen T.; Davydova I.; Khodjaeva Z.; Thorsen P.; Kacerovsky M.; Tambor V.; Massinen T.; Nace J.; Arora C.; Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reproductive Sciences 2011 18 11 1046 1070 2-s2.0-80055009691 10.1177/1933719111415548
41. Conde-Agudelo A.; Papageorghiou A. T.; Kennedy S. H.; Villar J.; Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. British Journal of Obstetrics and Gynaecology 2011 118 9 1042 1054 2-s2.0-79960352019 10.1111/j.1471-0528.2011. 02923.x
42. Stout M. J.; Goetzinger K. R.; Tuuli M. G.; First trimester serum analytes, maternal characteristics and ultrasound markers to predict pregnancies at risk for preterm birth. Placenta 2013 34 1 14 19
43. Beta J.; Akolekar R.; Ventura W.; Syngelaki A.; Nicolaides K. H.; Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks. Prenatal Diagnosis 2011 31 1 75 83 2-s2.0-78650848116 10.1002/pd.2662
44. Parra-Cordero M.; Sepúlveda-Martínez A.; Rencoret G.; Is there a role for cervical assessment and uterine artery Doppler performed during the first trimester of pregnancy as a screening test for spontaneous preterm delivery? Ultrasound in Obstetrics & Gynecology 2013 10.1002/uog.12465
45. Sananes N.; Meyer N.; Gaudineau A.; Prediction of spontaneous preterm delivery in the first trimester of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive 2013 171 1 18 22
46. Celik E.; To M.; Gajewska K.; Smith G. C. S.; Nicolaides K. H.; Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound in Obstetrics and Gynecology 2008 31 5 549 554 2-s2.0-51949100288 10.1002/uog.5333
47. Iams J. D.; Clinical practice. Prevention of preterm parturition. The New England Journal of Medicine 2014 370 3 254 261
48. Hassan S. S.; Romero R.; Vidyadhari D.; Fusey S.; Baxter J. K.; Khandelwal M.; Vijayaraghavan J.; Trivedi Y.; Soma-Pillay P.; Sambarey P.; Dayal A.; Potapov V.; O'Brien J.; Astakhov V.; Yuzko O.; Kinzler W.; Dattel B.; Sehdev H.; Mazheika L.; Manchulenko D.; Gervasi M. T.; Sullivan L.; Conde-Agudelo A.; Phillips J. A.; Creasy G. W.; Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound in Obstetrics and Gynecology 2011 38 1 18 31 2-s2.0-79955959403 10.1002/uog.9017
49. Berghella V.; Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. American Journal of Obstetrics and Gynecology 2012 206 5 376 386 2-s2.0-84860316016 10.1016/j.ajog.2012.03.010
50. Muglia L. J.; Katz M.; The enigma of spontaneous preterm birth. The New England Journal of Medicine 2010 362 6 484 535 2-s2.0-76649105134 10.1056/NEJMra0904308
51. Dabelea D.; Snell-Bergeon J. K.; Hartsfield C. L.; Bischoff K. J.; Hamman R. F.; McDuffie R. S.; Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: kaiser Permanente of Colorado GDM screening program. Diabetes Care 2005 28 3 579 584 2-s2.0-14644401737 10.2337/diacare.28.3.579 (Pubitemid 40315316)
52. Moses R. G.; Morris G. J.; Petocz P.; Sangil F.; Garg D.; The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Medical Journal of Australia 2011 194 7 338 340 2-s2.0-79955489588
53. HAPO Study Cooperative Research Group, Hyperglycemia and adverse pregnancy outcomes. The New England Journal of Medicine 2008 358 19 1991 2002
54. Solomon C. G.; Willett W. C.; Carey V. J.; Rich-Edwards J.; Hunter D. J.; Colditz G. A.; Stampfer M. J.; Speizer F. E.; Spiegelman D.; Manson J. E.; A prospective study of pregravid determinants of gestational diabetes mellitus. Journal of the American Medical Association 1997 278 13 1078 1083 2-s2.0-0030774499 (Pubitemid 27418334)
55. Tobias D. K.; Zhang C.; Van Dam R. M.; Bowers K.; Hu F. B.; Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 2011 34 1 223 229 2-s2.0-79951720172 10.2337/dc10-1368
56. Karamanos B.; Thanopoulou A.; Anastasiou E.; Relation of the Mediterranean diet with the incidence of gestational diabetes. European Journal of Clinical Nutrition 68 1 8 13 10.1038/ejcn.2013.177
57. Riskin-Mashiah S.; Damti A.; Younes G.; Auslender R.; First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. European Journal of Obstetrics Gynecology and Reproductive Biology 2010 152 2 163 167 2-s2.0-77957755014 10.1016/j.ejogrb.2010.05.036
58. Mcintire D. D.; Bloom S. L.; Casey B. M.; Leveno K. J.; Birth weight in relation to morbidity and mortality among newborn infants. The New England Journal of Medicine 1999 340 16 1234 1238 2-s2.0-0033594375 10.1056/ NEJM199904223401603 (Pubitemid 29181643)
59. Barker D. J. P.; Eriksson J. G.; Forsén T.; Osmond C.; Fetal origins of adult disease: Strength of effects and biological basis. International Journal of Epidemiology 2002 31 6 1235 1239 2-s2.0-12244264222 10.1093/ije/31.6.1235 (Pubitemid 36204489)
60. Roberge S.; Nicolaides K. H.; Demers S.; Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound in Obstetrics & Gynecology 2013 41 5 491 499
61. Sarmiento A.; Casasbuenas A.; Rodriguez N.; First-trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population. Prenat Diagn 2013 33 1 21 24
62. Collins S. L.; Stevenson G. N.; Noble J. A.; Impey L. Rapid calculation of standardized placental volume at 11 to 13 weeks and the prediction of small for gestational age babies. Ultrasound in Medicine & Biology 2013 39 2 253 260
63. Wilson J. M. G.; Jungner G.; Principles and Practice of Screening for Disease 1968 Public health papers no. 34 Geneva, Switzerland World Health Organization
64. Harris J. M.; Franck L.; Michie S.; Assessing the psychological effects of prenatal screening tests for maternal and foetal conditions: a systematic review. Journal of Reproductive and Infant Psychology 2013 30 222 246